New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
10:02 EDTMDRXAllscripts gaps up after results, levels to watch
Shares are up over 10.3% at time of writing, after earnings last night after the close. At the current price of $12.35, next resistance is at $12.85. Support is at $11.98.
News For MDRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
08:20 EDTMDRXAllscripts takes $200M equity position in NantHealth
Allscripts announced they have taken a significant step forward in their strategic partnership through two cross-investments and a strengthening of their commercial agreement. The investments include Allscripts' purchase of a 10% equity stake in NantHealth for $200M in cash. In addition, NantCapital, LLC, the personal investment vehicle of Dr. Patrick Soon-Shiong, founder of NantHealth, has made a $100M investment into Allscripts.
June 24, 2015
08:27 EDTMDRXAllscripts management to meet with Evercore ISI
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use